title: Inducible cardiomyocyte-specific gene disruption directed by the rat Tnnt2 promoter in the mouse.
abstract: We developed a conditional and inducible gene knockout methodology that allows effective gene deletion in mouse cardiomyocytes. This transgenic mouse line was generated by coinjection of two transgenes, a "reverse" tetracycline-controlled transactivator (rtTA) directed by a rat cardiac troponin T (Tnnt2) promoter and a Cre recombinase driven by a tetracycline-responsive promoter (TetO). Here, Tnnt2-rtTA activated TetO-Cre expression takes place in cardiomyocytes following doxycycline treatment. Using two different mouse Cre reporter lines, we demonstrated that expression of Cre recombinase was specifically and robustly induced in the cardiomyocytes of embryonic or adult hearts following doxycycline induction, thus, allowing cardiomyocyte-specific gene disruption and lineage tracing. We also showed that rtTA expression and doxycycline treatment did not compromise cardiac function. These features make the Tnnt2-rtTA;TetO-Cre transgenic line a valuable genetic tool for analysis of spatiotemporal gene function and cardiomyocyte lineage tracing during developmental and postnatal periods.
authors.affiliation: Department of Genetics, Albert Einstein College of Medicine of Yeshiva University, Price Center 420, 1301 Morris Park Avenue, Bronx, NY 10461, USA.
authors.forename: Bingruo
authors.initials: B
authors.lastname: Wu
authors.forename: Bin
authors.initials: B
authors.lastname: Zhou
authors.forename: Yidong
authors.initials: Y
authors.lastname: Wang
authors.forename: Hsiu-Ling
authors.initials: HL
authors.lastname: Cheng
authors.forename: Calvin T
authors.initials: CT
authors.lastname: Hang
authors.forename: William T
authors.initials: WT
authors.lastname: Pu
authors.forename: Ching-Pin
authors.initials: CP
authors.lastname: Chang
authors.forename: Bin
authors.initials: B
authors.lastname: Zhou
mesh_terms: D000818:Animals; D000831:Animals, Newborn; D004318:Doxycycline / Q000494:pharmacology; D004622:Embryo, Mammalian / Q000187:drug effects / Q000196:embryology / Q000378:metabolism*; D005260:Female; D005455:Fluorescent Antibody Technique; D018507:Gene Expression Regulation, Developmental / Q000187:drug effects; D049452:Green Fluorescent Proteins / Q000235:genetics / Q000378:metabolism; D006321:Heart / Q000196:embryology / Q000254:growth & development; D007150:Immunohistochemistry; D019426:Integrases / Q000235:genetics / Q000378:metabolism; D007668:Kidney / Q000196:embryology / Q000254:growth & development / Q000378:metabolism; D008099:Liver / Q000196:embryology / Q000254:growth & development / Q000378:metabolism; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D008822:Mice, Transgenic; D009206:Myocardium / Q000378:metabolism; D032383:Myocytes, Cardiac / Q000166:cytology / Q000187:drug effects / Q000378:metabolism*; D011401:Promoter Regions, Genetic / Q000235:genetics*; D051381:Rats; D020133:Reverse Transcriptase Polymerase Chain Reaction; D015534:Trans-Activators / Q000235:genetics / Q000378:metabolism; D020107:Troponin T / Q000235:genetics* / Q000378:metabolism*
chemical_list: D015534:Trans-Activators; D020107:Troponin T; D049452:Green Fluorescent Proteins; C045073:Cre recombinase; D019426:Integrases; D004318:Doxycycline